X-ray crystallography: Assessment and validation of proteinsmall molecule complexes for drug discovery

Expert Opinion on Drug Discovery

Volumn 6, Issue 8, 2011, Pages 771-782

  Cooper, David R ^a,b   Porebski, Przemyslaw J ^a,b   Chruszcz, Maksymilian ^a,b   Minor, Wladek ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Data mining; Drug design; Ligands; Macromolecular crystallography; Structural biology; Structure validation

Indexed keywords

LIGAND; PROTEIN;

CHEMICAL STRUCTURE; COMPLEX FORMATION; CRYSTAL STRUCTURE; MACROMOLECULE; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULE; PRIORITY JOURNAL; PROTEIN DATA BANK; PROTEIN INTERACTION; REVIEW; VALIDATION PROCESS; X RAY CRYSTALLOGRAPHY;

EID: 79960476804     PISSN: 17460441     EISSN: 1746045X     Source Type: Journal    
DOI: 10.1517/17460441.2011.585154     Document Type: Review

References (68)

1. Hol WG. Protein crystallography and drug design. Arzneimittel-Forschung 1989;39:1016-18
2. Congreve M, Murray CW, Blundell TL. Structural biology and drug discovery. Drug Discov Today 2005;10:895-907
3. Zheng H, Chordia M, Cooper DR, et al. CheckMyMetal (CMM): Validation of metal binding sites in protein structures. In preparation
4. Chruszcz M, Borek D, Domagalski M, et al. X-ray diffraction experiment - the last experiment in the structure elucidation process. Structural Genomics, Part C. San Diego: Elsevier Academic Press Inc 2009:23-40
5. Chruszcz M, Wlodawer A, Minor W. Determination of protein structures - a series of fortunate events. Biophys J 2008;95:1-9
6. Hartshorn MJ, Murray CW, Cleasby A, et al. Fragment-based lead discovery using X-ray crystallography. J Med Chem 2005;48:403-13 (Pubitemid 40139783)
7. Jhoti H, Cleasby A, Verdonk M, Williams G. Fragment-based screening using X-ray crystallography and NMR spectroscopy. Curr Opin Chem Biol 2007;11:485-93 (Pubitemid 47588996)
8. Scapin G. Structural biology and drug discovery. Curr Pharm Des 2006;12:2087-97 (Pubitemid 43891405)
9. Wlodawer A, Minor W, Dauter Z, Jaskolski M. Protein crystallography for non-crystallographers, or how to get the best (but not more) from published macromolecular structures. FEBS J 2008;275:1-21 (Pubitemid 350294067)
10. Carvalho AL, Trincao J, Romao MJ. X-ray crystallography in drug discovery. Methods Mol Biol 2009;572:31-56
11. Walkinshaw MD. Protein targets for structure-based drug design. Med Res Rev 1992;12:317-72
12. Murray CW, Blundell TL. Structural biology in fragment-based drug design. Curr Opin Struct Biol 2010;20:497-507
13. Nienaber VL, Richardson PL, Klighofer V, et al. Discovering novel ligands for macromolecules using X-ray crystallographic screening. Nat Biotechnol 2000;18:1105-8
14. Hajduk PJ, Greer J. A decade of fragment-based drug design: strategic advances and lessons learned. Nat Rev 2007;6:211-19 (Pubitemid 46344625)
15. Berman HM, Battistuz T, Bhat TN, et al. The Protein Data Bank. Acta Crystallogr 2002;D58:899-907 (Pubitemid 34653017)
16. Zheng H, Chruszcz M, Lasota P, et al. Data mining of metal ion environments present in protein structures. J Inorg Biochem 2008;102:1765-76
17. Allen FH. The cambridge structural database: a quarter of a million crystal structures and rising. Acta Crystallogr 2002;B58:380-8 (Pubitemid 135702674)
18. Chruszcz M, Domagalski M, Osinski T, et al. Unmet challenges of structural genomics. Curr Opin Struct Biol 2010;20:587-97
19. Hooft RW, Vriend G, Sander C, Abola EE. Errors in protein structures. Nature 1996;381:272
20. Laskowski RA, Macarthur MW, Moss DS, Thornton JM. Procheck - a Program to check the stereochemical quality of protein structures. J Appl Crystallogr 1993;26:283-91
21. Ramachandran GN, Ramakrishnan C, Sasisekharan V. Stereochemistry of polypeptide chain configurations. J Mol Biol 1963;7:95-9
22. Adams PD, Afonine PV, Bunkoczi G, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr 2010;66:213-21
23. Chen VB, Arendall WB 3rd, Headd JJ, et al. MolProbity: All-atom structure validation for macromolecular crystallography. Acta Crystallogr 2010;D66:12-21
24. Davis IW, Leaver-Fay A, Chen VB, et al. MolProbity: All-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 2007;35:W375-83
25. Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr 2010;D66:486-501
26. Berjanskii M, Liang Y, Zhou J, et al. PROSESS: a protein structure evaluation suite and server. Nucleic Acids Res 2010;38 Suppl:W633-40
27. Altschul SF, Gish W, Miller W, et al. Basic local alignment search tool. J Mol Biol 1990;215:403-10
28. Minor W, Cymborowski M, Otwinowski Z, Chruszcz M. HKL-3000: the integration of data reduction and structure solution-from diffraction images to an initial model in minutes. Acta Crystallogr 2006;D62:859-66 (Pubitemid 44125661)
29. Cymborowski M, Klimecka M, Chruszcz M, et al. To automate or not to automate: this is the question. J Struct Funct Genomics 2010;11:211-21
30. Miller G. Scientific publishing. A scientists nightmare: software problem leads to five retractions. Science 2006;314:1856-7
31. Nicholls A, McGaughey GB, Sheridan RP, et al. Molecular shape and medicinal chemistry: a perspective. J Med Chem 2010;53:3862-86
32. Malde AK, Mark AE. Challenges in the determination of the binding modes of non-standard ligands in X-ray crystal complexes. J Comput Aided Mol Des 2011;25:1-12
33. Kleywegt GJ. On vital aid: the why, what and how of validation. Acta Crystallogr 2009;D65:134-9
34. Kleywegt GJ, Henrick K, Dodson EJ, van Aalten DM. Pound-wise but penny-foolish: How well do micromolecules fare in macromolecular refinement? Structure 2003;11:1051-9 (Pubitemid 37103067)
35. Andrejasic M, Praaenikar J, Turk D. PURY: a database of geometric restraints of hetero compounds for refinement in complexes with macromolecular structures. Acta Crystallogr 2008;D64:1093-109
36. Kleywegt GJ. Crystallographic refinement of ligand complexes. Acta Crystallogr 2007;D63:94-100 (Pubitemid 46141484)
37. Evans PR. An introduction to stereochemical restraints. Acta Crystallogr 2007;D63:58-61 (Pubitemid 46141480)
38. Schuttelkopf AW, van Aalten DM. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr 2004;D60:1355-63 (Pubitemid 41079731)
39. Moriarty NW, Grosse-Kunstleve RW, Adams PD. electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation. Acta crystallogr 2009;65:1074-80
40. Gront D. In preparation
41. Kleywegt GJ, Harris MR. ValLigURL: a server for ligand-structure comparison and validation. Acta crystallogr 2007;63:935-8 (Pubitemid 47094577)
42. Adams PD, Gopal K, Grosse-Kunstleve RW, et al. Recent developments in the PHENIX software for automated crystallographic structure determination. J Synchrotron Radiat 2004;11:53-5 (Pubitemid 40085633)
43. Grabowski M, Chruszcz M, Zimmerman MD, et al. Benefits of structural genomics for drug discovery research. Infect Disord Drug Targets 2009;9:459-74
44. Choi J, Chon JK, Kim S, Shin W. Conformational flexibility in mammalian 15S-lipoxygenase: Reinterpretation of the crystallographic data. Proteins 2008;70:1023-32 (Pubitemid 351161958)
45. Saikatendu KS, Zhang X, Kinch L, et al. Structure of a conserved hypothetical protein SA1388 from S. aureus reveals a capped hexameric toroid with two PII domain lids and a dinuclear metal center. BMC Struct Biol 2006;6:27
46. Poon BK, Grosse-Kunstleve RW, Zwart PH, Sauter NK. Detection and correction of underassigned rotational symmetry prior to structure deposition. Acta crystallogr 2010;D66:503-13
47. Joosten RP, Vriend G. PDB improvement starts with data deposition. Science 2007;317:195-6 (Pubitemid 47076180)
48. Joosten RP, Womack T, Vriend G, Bricogne G. Re-refinement from deposited X-ray data can deliver improved models for most PDB entries. Acta Crystallogr 2009;D65:176-85
49. Kim YJ, Doyle ML. Structural mass spectrometry in protein therapeutics discovery. Anal Chem 2010;82:7083-9
50. Gibbs AC, Abad MC, Zhang X, et al. Electron density guided fragment-based lead discovery of ketohexokinase inhibitors. J Med Chem 2010;53:7979-91
51. Derewenda ZS, Vekilov PG. Entropy and surface engineering in protein crystallization. Acta Crystallogr 2006;D62:116-24
52. Dong A, Xu X, Edwards AM, et al. In situ proteolysis for protein crystallization and structure determination. Nat Methods 2007;4:1019-21 (Pubitemid 350201773)
53. Koide S. Engineering of recombinant crystallization chaperones. Curr Opin Struct Biol 2009;19:449-57
54. McPherson A, Cudney B. Searching for silver bullets: an alternative strategy for crystallizing macromolecules. J Struct Biol 2006;156:387-406 (Pubitemid 44751480)
55. Joachimiak A. High-throughput crystallography for structural genomics. Curr Opin Struct Biol 2009;19:573-84
56. Broennimann C, Eikenberry EF, Henrich B, et al. The PILATUS 1M detector. J Synchrotron Radiat 2006;13:120-30
57. Gruner SM, Tate MW, Eikenberry EF. Charge-coupled device area x-ray detectors. Rev Sci Instruments 2002;73:2815-42
58. Kraft P, Bergamaschi A, Broennimann C, et al. Performance of single-photon-counting PILATUS detector modules. J Synchrotron Radiat 2009;16:368-75
59. Sakabe K, Sasaki K, Watanabe N, et al. Large-format imaging plate and Weissenberg camera for accurate protein crystallographic data collection using synchrotron radiation. J Synchrotron Radiat 1997;4:136-46
60. The CCP4 suite: programs for protein crystallography. Acta Crystallogr 1994;D50:760-3
61. Warren GL, Andrews CW, Capelli AM, et al. A critical assessment of docking programs and scoring functions. J Med Chem 2006;49:5912-31 (Pubitemid 44484938)
62. Nam KH, Sung MW, Hwang KY. Structural insights into the substrate recognition properties of beta-glucosidase. Biochem Biophys Res Commun 2010;391:1131-5
63. Myler PJ, Stacy R, Stewart L, et al. The Seattle Structural Genomics Center for Infectious Disease (SSGCID). Infect Disord Drug Targets 2009;9:493-506
64. Anderson WF. Structural genomics and drug discovery for infectious diseases. Infect Disord Drug Targets 2009;9:507-17
65. Minor W, Steczko J, Stec B, et al. Crystal structure of soybean lipoxygenase L-1 at 1.4 A resolution. Biochemistry 1996;35:10687-701 (Pubitemid 26279648)
66. Joosten RP, Salzemann J, Bloch V, et al. PDB-REDO: automated re-refinement of X-ray structure models in the PDB. J Appl Crystallogr 2009;42:376-84
67. Furet P, Meyer T, Strauss A, et al. Structure-based design and protein X-ray analysis of a protein kinase inhibitor. Bioorg Med Chem Lett 2002;12:221-4 (Pubitemid 34037972)
68. Kurumbail RG, Stevens AM, Gierse JK, et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 1996;384:644-8